Caro-Vega Yanink, del Rio Carlos, Lima Viviane Dias, Lopez-Cervantes Malaquias, Crabtree-Ramirez Brenda, Bautista-Arredondo Sergio, Colchero M Arantxa, Sierra-Madero Juan
Faculty of Medicine, Universidad Nacional Autónoma de México, Mexico City, Mexico; Department of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubiran, Mexico City, Mexico.
Hubert Department of Global Health, Rollins School of Public Health & Emory Center for AIDS Research, Atlanta, Georgia, United States of America.
PLoS One. 2015 Aug 24;10(8):e0136534. doi: 10.1371/journal.pone.0136534. eCollection 2015.
To estimate the impact of late ART initiation on HIV transmission among men who have sex with men (MSM) in Mexico.
An HIV transmission model was built to estimate the number of infections transmitted by HIV-infected men who have sex with men (MSM-HIV+) MSM-HIV+ in the short and long term. Sexual risk behavior data were estimated from a nationwide study of MSM. CD4+ counts at ART initiation from a representative national cohort were used to estimate time since infection. Number of MSM-HIV+ on treatment and suppressed were estimated from surveillance and government reports. Status quo scenario (SQ), and scenarios of early ART initiation and increased HIV testing were modeled.
We estimated 14239 new HIV infections per year from MSM-HIV+ in Mexico. In SQ, MSM take an average 7.4 years since infection to initiate treatment with a median CD4+ count of 148 cells/mm3(25th-75th percentiles 52-266). In SQ, 68% of MSM-HIV+ are not aware of their HIV status and transmit 78% of new infections. Increasing the CD4+ count at ART initiation to 350 cells/mm3 shortened the time since infection to 2.8 years. Increasing HIV testing to cover 80% of undiagnosed MSM resulted in a reduction of 70% in new infections in 20 years. Initiating ART at 500 cells/mm3 and increasing HIV testing the reduction would be of 75% in 20 years.
A substantial number of new HIV infections in Mexico are transmitted by undiagnosed and untreated MSM-HIV+. An aggressive increase in HIV testing coverage and initiating ART at a CD4 count of 500 cells/mm3 in this population would significantly benefit individuals and decrease the number of new HIV infections in Mexico.
评估在墨西哥男男性行为者(MSM)中延迟启动抗逆转录病毒治疗(ART)对HIV传播的影响。
构建一个HIV传播模型,以估计男男性行为感染HIV者(MSM-HIV+)在短期和长期内传播的感染数量。性风险行为数据来自一项针对MSM的全国性研究。从一个具有代表性的全国队列中获取ART启动时的CD4+细胞计数,以估计感染后的时间。接受治疗且病毒得到抑制的MSM-HIV+数量通过监测和政府报告进行估计。对现状情景(SQ)、早期启动ART情景和增加HIV检测情景进行了建模。
我们估计墨西哥每年有14239例由MSM-HIV+导致的新HIV感染。在现状情景下,MSM从感染到开始治疗平均需要7.4年,CD4+细胞计数中位数为148个细胞/mm³(第25-75百分位数为52-266)。在现状情景下,68%的MSM-HIV+不知道自己的HIV感染状况,传播了78%的新感染病例。将ART启动时的CD4+细胞计数提高到350个细胞/mm³,可将感染后的时间缩短至2.8年。将HIV检测覆盖率提高到涵盖80%未诊断的MSM,20年内新感染病例将减少70%。在CD4+细胞计数为500个细胞/mm³时启动ART并增加HIV检测,20年内感染减少率将达到75%。
墨西哥大量新的HIV感染是由未诊断和未治疗的MSM-HIV+传播的。积极提高该人群的HIV检测覆盖率,并在CD4细胞计数为500个细胞/mm³时启动ART,将显著造福个体并减少墨西哥新HIV感染病例的数量。